Atria Wealth Solutions, Inc. Sorrento Therapeutics, Inc. Transaction History

Atria Wealth Solutions, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Aug 30, 2023	BUY	$0.74 - $1.83 $40,774 - $100,833	55,100 New	55,100 $49,000
Q4 2022 Feb 13, 2023	BUY	$0.74 - $1.83 $1,813 - $4,483	2,450 Added 4.57%	56,050 $49,000
Q3 2022 Nov 14, 2022	SELL	$1.51 - $2.88 $22,385 - $42,696	-14,825 Reduced 21.67%	53,600 $84,000
Q2 2022 Aug 15, 2022	BUY	$1.24 - $2.33 $51,770 - $97,277	41,750 Added 156.51%	68,425 $138,000
Q1 2022 May 16, 2022	BUY	$2.0 - $4.9 $53,350 - $130,707	26,675 New	26,675 $62,000

5.53M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Atria Wealth Solutions, Inc., based on Form 13F filings with the SEC.

Stay updated on Atria Wealth Solutions, Inc. with notifications on news.